INTRANASALE VERABREICHUNG

European patent · EP3220989 · In force

Register entry

Publication number
EP3220989
Application number
EP15798061
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 19, 2015
Published
Sep 27, 2017
Granted
Jun 24, 2020
Protection ends at the latest
Nov 18, 2035
Next annual fee due
Nov 30, 2026
IPC classes
A61M 15/08 (2006.01)
A61M 15/00 (2006.01)
Priority
US 201462081742 P 19.11.2014
PCT application
PCT/EP2015/077166 19.11.2015
PCT publication
WO2016/079271 26.05.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 29, 2025

    Change

    Published in Swissreg on 29.12.2025

  2. Dec 1, 2024

    Change

    Published in Swissreg on 01.12.2024

  3. Dec 1, 2023

    Change

    Published in Swissreg on 01.12.2023

  4. Dec 1, 2022

    Change

    Published in Swissreg on 01.12.2022

  5. Oct 18, 2022

    Transferred

    Owner
    Optinose AS, Postboks 288 Roa, 0702 Oslo, Norway → OPTINOSE, INC., 1020 Stony Hill Road, Ste 300, Yardley, PA 19067, USA

    Published in Swissreg on 18.10.2022

  6. Aug 5, 2020

    Agent entered

    Representative
    Hepp Wenger Ryffel AG, Friedtalweg 5, 9500 Wil / SG

    Published in Swissreg on 05.08.2020

  7. Jun 24, 2020

    Granted

    Published in Swissreg on 24.06.2020

Parties

Holder

OPTINOSE, INC.

1020 Stony Hill Road, Ste 300, Yardley, PA 19067, US

Agent

Hepp Wenger Ryffel AG

Friedtalweg 5, 9500 Wil / SG

Inventor

DJUPESLAND, Per Gisle

N-0702 Oslo, NO

SHELDRAKE, Colin David

South Marston Park Wiltshire SN3 4TG, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.